('fig', 21);('auc', 18);('texture model', 18);('dutch', 16);('pmd', 14);('ml', 12);('hologicprocessed', 11);('ieee transactions medical imaging vol', 10);('ltcs', 10);('ci', 10);('xx x', 9);('healthy women', 7);('series experiments', 7);('ics', 6);('aucs', 6);('breast cancer', 5);('risk models', 5);('raw views', 5);('domain adaptation technique', 5);('aucic', 5);('gail', 4);('mirai', 4);('breast', 4);('training datasets', 4);('training dataset', 4);('ics ltcs', 4);('aucltc', 4);('erratic convergence', 3);('danish women', 3);('breast cancer risk', 3);('furthermore', 3);('longterm risk', 3);('january', 3);('ors', 3);('boadicea', 3);('texture quantile', 3);('apr', 3);('j natl', 3);('inst', 3);('neurips', 3);('mammographybased', 2);('independent datasets', 2);('siemens', 2);('europe', 2);('copenhagen', 2);('copenhagen denmark', 2);('highrisk women', 2);('shortterm breast cancer risk', 2);('large datasets', 2);('diagnostic model', 2);('breast cancer risk models', 2);('training samples', 2);('cancer contralateral', 2);('yala', 2);('fiveyear risk', 2);('hologic', 2);('population breast cancer', 2);('women age', 2);('flow', 2);('danish training dataset', 2);('december', 2);('august', 2);('sdcs ics ltcs', 2);('raw mammographic', 2);('cancers', 2);('training', 2);('woman cancer', 2);('longterm risk estimation', 2);('raw view', 2);('example', 2);('different flavors', 2);('resnet18', 2);('imagenet', 2);('baseline performance', 2);('flavor augmentation', 2);('danish training dataset flavor', 2);('nl', 2);('training dataset size', 2);('full risk model', 2);('small neural network', 2);('lastly', 2);('stage folds', 2);('cp', 2);('aucs ics', 2);('aucsic', 2);('random performance', 2);('baseline p0001', 2);('d4', 2);('highdensity women', 2);('unseen flavor', 2);('clinical workflow', 2);('gastounioti', 2);('nov', 2);('radiology', 2);('risk', 2);('deep learning', 2);('ieee trans med imaging', 2);('may', 2);('clinical oncology', 2);('cvpr', 2);('jul', 2);('x november', 1);('robust crossvendor mammographic texture', 1);('augmentationbased domain adaptation longterm breast', 1);('risk andreas lauritzen catarina', 1);('eulerchelpin elsebeth lynge ilse vejborg mads nielsen nico karssemeijer martin lillholm abstract', 1);('relevant risk models', 1);('robust domain shifts', 1);('different populations mammographic devices', 1);('modern risk models ensure adaptation', 1);('precursors cancer systemicglobal mammographic information', 1);('short longterm risk', 1);('limit performance', 1);('robust crossvendor model longterm risk assessment', 1);('domain adaption technique', 1);('flavorization mammographic', 1);('generalization unseen vendordomain', 1);('diagnosedpotential malignant findings', 1);('systemicglobal breast tissue', 1);('mammographic texture indicative', 1);('future breast cancer', 1);('casecontrol dataset robust ensemble texture model', 1);('prediction interval cancers', 1);('risk factors models', 1);('views results', 1);('longterm risk adapting unseen', 1);('vendordomain model', 1);('ltcs index terms', 1);('breast cancer risk mammography domain adaptation data augmentation noisy labels', 1);('introduction', 1);('reast cancer', 1);('death women worldwide1', 1);('approximately', 1);('union us', 1);('breast cancer diagnosis lifetime', 1);('populationbased', 1);('eurostars', 1);('e9714 ibscreen lauritzen nielsen lillholm', 1);('computer', 1);('science university', 1);('emails aldikudk madsndikudk grumsedikudk von', 1);('eulerchelpin e lynge', 1);('public health university', 1);('email myeusundkudk elsebethsundkudk', 1);('vejborg', 1);('breast examinations gentofte', 1);('gentofte denmark', 1);('email ilsevejborgregionhdk', 1);('n karssemeijer screenpoint', 1);('ec nijmegen netherlands', 1);('email nicokarssemeijerscreenpointmedcom mammography xray', 1);('early breast cancer signs', 1);('screening', 1);('employ onesizefitsall approach women', 1);('equal conditions approach', 1);('low breast cancer incidence general lack', 1);('personalized', 1);('radiologists resources', 1);('total cost', 1);('medical data', 1);('medical history', 1);('tyrercuzick tc', 1);('model incorporate genetic information eg', 1);('brca', 1);('whereas', 1);('extensive data collection', 1);('programs laborious', 1);('conversely', 1);('classification schemes', 1);('wolfe boyd', 1);('amount radiodense tissue eg lobules ducts', 1);('relative amount fatty tissue', 1);('categorize highrisk women', 1);('dense fatty tissue percentage mammographic density', 1);('risk factor l', 1);('tabr', 1);('distribution denseparenchymal breast tissue', 1);('risk factor', 1);('breast heterogeneity', 1);('identify highrisk women', 1);('mammographic texture', 1);('mammographic', 1);('density texture', 1);('global features mammogram', 1);('longterm breast cancer risk contrary b', 1);('actual cancerous lesions precursors', 1);('suspicious findings', 1);('negative result breast cancer', 1);('breast cancer predictive', 1);('minimal signs', 1);('cancer precursors texture density', 1);('machine learning', 1);('digital mammograms', 1);('risk models compatible', 1);('programs digital mammograms', 1);('available analysis', 1);('precursors breast density', 1);('clinical settings', 1);('longterm risk models', 1);('terms clinical utility distinguish', 1);('firstly', 1);('detect segment', 1);('suspicious local findings', 1);('estimate shortterm risk', 1);('secondly', 1);('estimate longterm risk learning systemic differences tissue composition high lowrisk women eg mammographic texture density patterns indicative', 1);('thirdly', 1);('immediate short longterm risk learning', 1);('visible cancersprecursors systemicglobal differences mammographic texture', 1);('visible lesion', 1);('predictive longterm risk', 1);('model learning', 1);('clinically', 1);('risk models work', 1);('multiple mammographic devices', 1);('output mammographic device', 1);('pipelines differ', 1);('sites preferences', 1);('models suffer domain', 1);('medical images adapt unseen domains eg mammograms', 1);('mammographic device', 1);('devicedomain', 1);('depth literature', 1);('relevant robust crossvendor texture model longterm breast cancer risk', 1);('main contributions study', 1);('architecture texture longterm breast cancer risk', 1);('screenavailable information ensure optimal training', 1);('weak longterm risk signal train', 1);('training longterm risk', 1);('erratic convergence alleviate', 1);('casecontrol training dataset ensemble texture model', 1);('ensure adaptation', 1);('data augmentation technique', 1);('multiple flavors texture model', 1);('populations vendors', 1);('ii related work breast', 1);('cancer risk', 1);('different contexts', 1);('distinguish models', 1);('detection risk assessment combination report results', 1);('sections describe', 1);('diagnostic', 1);('risk estimation gastounioti', 1);('profound ai', 1);('tool icad detectssegments', 1);('suspicious lesions compatible', 1);('hologic ge siemens', 1);('devices model', 1);('age masses microcalcifications asymmetry breast density', 1);('shortterm risk estimate cohort screen', 1);('negative women twoyear followup model', 1);('area receiver', 1);('characteristic curve', 1);('longterm risk estimates', 1);('similar approach estimate shortterm risk', 1);('longterm risk model', 1);('findings training', 1);('liu', 1);('mammographic texture model risk estimation kallenberg', 1);('autoencoder multiscale image patches', 1);('fashion model', 1);('measure texture risk', 1);('tissue patterns', 1);('followup training validation datasets', 1);('small population singlevendor', 1);('raw views c', 1);('conflated', 1);('risk estimation dembrower', 1);('inceptionresnetv2', 1);('model estimate risk multiscale image patches mammograms model', 1);('age device acquisition parameters', 1);('views cancerfree', 1);('model evaluation robustness', 1);('resnet', 1);('encoder transformer model aggregate', 1);('risk factor predictor', 1);('additivehazard layer estimate risk', 1);('multiple timepoints', 1);('adversarial approach', 1);('able generalize', 1);('mammographic devices', 1);('systems vendor', 1);('adequate measure longterm risk estimation performance', 1);('mirais', 1);('ability adapt unseen vendors eg', 1);('siemens hologic', 1);('problem learning', 1);('longterm risk datadriven fashion', 1);('learning task perstudy labels', 1);('likely overfit learning longterm risk irrelevant', 1);('due weak longterm risk signal', 1);('visible features model overparameterization', 1);('additional', 1);('present highrisk women eg high density texturerisk women', 1);('followup lead', 1);('literature context', 1);('models terms training', 1);('mix detection futurecurrent cancers', 1);('different intervals validation', 1);('accommodate limitations', 1);('iii materials methods', 1);('sections describe methods', 1);('describe efforts stabilize training describe', 1);('enable crossvendor texture model', 1);('describe training procedure ensemble texture model study', 1);('data inspection', 1);('patient safety', 1);('collection analysis relevant data reference number', 1);('screening populations datasets', 1);('capital region denmark', 1);('mammomat inspiration', 1);('siemens healthineers dutch', 1);('utrecht netherlands', 1);('lorad selenia', 1);('hologic screened', 1);('breast mammograms', 1);('diagram selection process', 1);('danish training', 1);('dataset b', 1);('selection', 1);('dataset c curation', 1);('training validation', 1);('visible', 1);('medical devices', 1);('foreign unknown objects disruptive image artifacts', 1);('recall women diagnostic tests breast cancers', 1);('invasive ductal carcinoma situ', 1);('clinical examination', 1);('mammography ultrasound needle biopsy', 1);('distinct groups', 1);('screendetected', 1);('sdc', 1);('interval cancers', 1);('ic', 1);('longterm cancers', 1);('ltc sdcs', 1);('women breast cancer diagnosis', 1);('breast cancer diagnosis', 1);('breast cancers', 1);('regardless recall practice', 1);('ltcs sdcs ics', 1);('1a 1b depict collection processes flow diagram', 1);('exclusion process women', 1);('visible artifacts', 1);('previous breast cancer diagnoses biopsy clips cancer contralateral breast breasts', 1);('november', 1);('maximum amount', 1);('training population group women', 1);('equal size datasets', 1);('dataset holdout', 1);('dataset measure performance models', 1);('independent limitation', 1);('evaluation texture model', 1);('danish data b', 1);('curation training data stabilize convergence', 1);('noisy labels', 1);('inherent difficulty task reference training texture model', 1);('erratic unstable convergence', 1);('reliable risk estimates', 1);('casecontrol dataset robust training curation process', 1);('stages noiseidentification stage', 1);('literature', 1);('models noisy', 1);('labels suggests training mentorteacher network filter samples generate pseudolabels student network', 1);('strategy training reference model noiseidentification stage', 1);('reference risk scores reference risk scores', 1);('stage exclude', 1);('ensemble folds ensemble texture model noiseidentification stage', 1);('healthy women age', 1);('year age difference', 1);('ensemble folds practice', 1);('cross validation method', 1);('age cancer groups', 1);('sdcicltchealthy', 1);('model performance cross', 1);('se folds', 1);('training ensemble model', 1);('healthy women views', 1);('unmatched', 1);('reference texture model', 1);('available views reference risk scores', 1);('training reference model', 1);('epochs training procedure', 1);('danish training datasets reference risk scores', 1);('available women', 1);('noiseidentification stage', 1);('ensemble fold', 1);('women healthy', 1);('reference risk', 1);('likely noisy samples', 1);('texture risk', 1);('reference risk cancer group', 1);('subset women future cancer', 1);('difficult classify', 1);('future cancer', 1);('lowrisk tissue patterns correlate', 1);('tissues healthy women cancer subtype correlate texture step', 1);('ensemble folds', 1);('reference risk cancer group age', 1);('unmatchedexcluded', 1);('cancer group reference risk', 1);('folds training robust', 1);('ensemble texture model', 1);('augmentationbased domain adaptation', 1);('relevant texture model', 1);('new target domains unseen processing types', 1);('methods domainadaptation', 1);('data augmentation adversarial trainings', 1);('adversarial', 1);('difficult train practice', 1);('target domain', 1);('classical image transformations adaptation', 1);('data augmentation outperform adversarial approaches', 1);('certain cases', 1);('augmentation single', 1);('different formats', 1);('image transformations steps', 1);('previous literature', 1);('breast mask distance map', 1);('rest grid', 1);('purposes grid lines scale tissue', 1);('blue orange lines edge tissue b', 1);('view example flavor', 1);('flavor', 1);('step mask', 1);('breast tissue', 1);('distance map', 1);('distance skinairboundary', 1);('2a background', 1);('removes burnedin view annotations', 1);('step pixel values breast tissue view position', 1);('logarithmic inverse sigmoid function', 1);('pixel value', 1);('breast tissue parameters', 1);('parameters values', 1);('max value', 1);('step edge tissue thickness', 1);('breast tissue contrast', 1);('addition enhancement mask', 1);('enhancement mask practice difference', 1);('original view', 1);('low pass', 1);('scaling', 1);('different vendors', 1);('flavor profile output tool', 1);('flavor profile', 1);('flavor profiles', 1);('2b shows example', 1);('view examples flavors', 1);('image conversion tool', 1);('training procedure texture model', 1);('procedure augmentation scheme trainingvalidation dataset', 1);('input single mammographic view', 1);('challenge dataset', 1);('layers output single', 1);('confidence measure model architecture', 1);('texture model architecture input view', 1);('thrice channel axis', 1);('map size', 1);('dropout layer probability dropout', 1);('batch normalization', 1);('bn', 1);('fc', 1);('relu', 1);('layers layer probability', 1);('bn fc', 1);('layer sigmoid activation single output neuron', 1);('distinguish cancer contralateral', 1);('women future cancer', 1);('binary cross entropy', 1);('bce', 1);('batch size', 1);('binary groundtruth label c', 1);('model model', 1);('adam', 1);('optimizer learning rate', 1);('vertical axis', 1);('mimic difference scanner positions', 1);('horizontal direction factor', 1);('final texture model ensemble', 1);('training dataset instance model', 1);('corresponding validation', 1);('cancer groups', 1);('positives views regardless training inference', 1);('pixel size', 1);('pixels inference', 1);('dataset viewlevel texture risk score average', 1);('confidence measures', 1);('instance model', 1);('screened', 1);('studylevel risk score', 1);('viewlevel risk scores', 1);('standard deviation', 1);('dataset experiments flavor augmentation', 1);('cases views', 1);('batch epoch', 1);('full training dataset model', 1);('epochs experiment section specifies experiment flavor augmentation', 1);('python', 1);('tensorflow', 1);('nvidia titan rtx gpu experiments', 1);('data curation section', 1);('reference texture models', 1);('noise stabilize training', 1);('opportunity analyze convergence noiseidentification', 1);('stages convergence plots', 1);('b c', 1);('raw views assess', 1);('proper adaptation domains', 1);('additional training data', 1);('presence clips surrogate', 1);('previous falsepositive screen', 1);('risk estimation', 1);('depicts fours series experiments flow diagram', 1);('trainformattestformattraindatasettestdataset eg flavprocdtrntst', 1);('boxes', 1);('training dataset view formats oval endpoints', 1);('view format', 1);('dk', 1);('proc testdutch', 1);('rfrisk', 1);('hologic siemens', 1);('able generalize flavor', 1);('series b', 1);('generalize unseen flavor flavor', 1);('essentially', 1);('unseen scanner', 1);('series c baseline performance', 1);('baseline performance texture', 1);('flavor augmentation assess performance', 1);('series texture model', 1);('terms data', 1);('new instances model', 1);('dataset flavor', 1);('risk factors', 1);('texture age presence clips', 1);('able identify highrisk subset women', 1);('maximize number', 1);('ics ltcs ii results', 1);('sections results', 1);('convergence reference texture model', 1);('appropriate significance', 1);('relationship texture', 1);('odds ratios', 1);('performance reference texture model fig', 1);('shows convergence', 1);('danish reference model', 1);('epochs noiseidentification stage top row', 1);('stage bottom row top row validation performances', 1);('convergence point', 1);('aucic cp', 1);('aucltc cp', 1);('stage fold', 1);('validation curves', 1);('curation training data folds overfit', 1);('equal convergence points', 1);('instances ensemble texture model inference', 1);('validation', 1);('danish training dataset top row', 1);('noiseidentification stage bottom row', 1);('stage b', 1);('detection performance risk', 1);('estimation performances', 1);('auc aucltc ltcs', 1);('aucic ics', 1);('positive completeness', 1);('aucic ltc ics ltcs', 1);('positives women', 1);('delong', 1);('different compute', 1);('confidence intervals', 1);('table aucs', 1);('ci ics ltcs ics ltcs', 1);('experiment auc ic auc ltc auc ic ltc', 1);('series rawrawntrdtst', 1);('series b flavflavntrdtst', 1);('series flavflavdntrdtst', 1);('series baseline results rawrawntrdtst rawrawdtrdtst', 1);('aucsltc', 1);('significant differences', 1);('aucsic aucsltc', 1);('pic024 pltc035', 1);('good adaptation', 1);('raw views robust model training rawflavntrdtst rawflavdtrdtst', 1);('series b results flavflavntrdtst flavflavdtrdtst', 1);('aucsltcs', 1);('results pic024 pltc09 flavflavntrdtst flavflavdtrdtst', 1);('different corresponding baseline rawrawntrdtst rawrawntrdtst pic057pltc064 pic076pltc039', 1);('flavor texture models', 1);('unseen flavor domain', 1);('loss risk estimation performance series c baseline results rawrawdtrntst', 1);('due difference curation datasets flavprocdtrntst', 1);('flavor model', 1);('views baseline', 1);('raw views rawprocdtrnltst', 1);('different flavflavdtrdtst pic017 pltc042', 1);('test series flavflavdntrdtst yield', 1);('flavflavntrdtst pic006 pltc014', 1);('flavflavdtrdtst pltc002 partial evidence', 1);('risk estimation performance flavflavdntrrfdtst', 1);('flavflavdntrdtst pltc0001', 1);('additional information longterm risk c', 1);('distribution cancers texture pmd', 1);('relevant highrisk subset women', 1);('entry shows percentage cancers texture vs', 1);('quantile quantiles', 1);('texture scores', 1);('pmds', 1);('healthy women entry', 1);('displays odds ratio cancer reference', 1);('d1 t1', 1);('b matrix shows distribution', 1);('texture pmd', 1);('diagonal top', 1);('matrix', 1);('b texture', 1);('texture', 1);('scores flavflavdntrdtst', 1);('quantiles', 1);('underneath', 1);('fisher', 1);('pvalue parentheses', 1);('top rows', 1);('texture quantile yields', 1);('ic ltc', 1);('reference group', 1);('facilitate selection', 1);('usable highrisk subset women', 1);('discussion', 1);('usable crossvendor robust texture model longterm breast cancer risk', 1);('texture model adapt domain unseen', 1);('large independent dataset texture model', 1);('healthy breast tissue', 1);('ensemble model', 1);('robust risk estimate', 1);('texture model domain adaptation abilities', 1);('series experiments results', 1);('different devices ensemble training', 1);('consistent results populations devices', 1);('rawflavntrdtst rawflavdtrdtst rawprocdtrntst', 1);('support clinical workflow', 1);('views series b experiments', 1);('new scanner', 1);('case flavor texture models', 1);('equal raw baseline counterparts', 1);('vendoragnostic flavor', 1);('enable integration', 1);('typical clinical workflow', 1);('series c experiments', 1);('train texture model', 1);('corresponding raw baseline', 1);('possible integration clinical workflow rawrawdtrntst', 1);('bias women', 1);('available series b c experiment', 1);('gain training', 1);('raw views need', 1);('sites scanners flavor augmentation', 1);('training crossvendor texture model', 1);('site data series experiment', 1);('performance results', 1);('close upper limit', 1);('particular model', 1);('age clips', 1);('comparison existing risk', 1);('traditional models', 1);('10year risk estimation', 1);('tc', 1);('years followup', 1);('risk factors personalfamilialreproductivehormonallifestyle factors polygenic risk scores breast density pathogenic variants', 1);('auc gail tc', 1);('study sample', 1);('tenth size texture model', 1);('screenavailable information', 1);('patient history gene data questionnaires', 1);('negative women', 1);('comparably', 1);('ic kallenberg', 1);('study results', 1);('clear improvement', 1);('dembrower', 1);('sixyear risk estimation dataset', 1);('texture models', 1);('months fiveyear risk estimation', 1);('validation datasets', 1);('comparable authors considers cancers', 1);('distribution time', 1);('adaptation unseen', 1);('views c', 1);('clinical relevance ics', 1);('reference group result', 1);('risk assessment', 1);('efficient flag highrisk', 1);('optimal texture', 1);('large proportion', 1);('low texture risk', 1);('highrisk hightexture women', 1);('limitations', 1);('texture model study', 1);('differences curation', 1);('flavors training', 1);('sufficient generalize vendors', 1);('similarity populations', 1);('intervals number readers', 1);('e conclusion', 1);('perspectives', 1);('relevant highrisk cohort', 1);('texture model longterm risk', 1);('workflow collaboration radiologists', 1);('texture correlates', 1);('certain subtypes breast cancer robust crossvendor texture model', 1);('followup demographic diversity', 1);('performance robustness', 1);('texture model estimates longterm risk detection model estimate immediateshortterm risk', 1);('findings precursors', 1);('combining', 1);('short longterm risk estimation weak risk signals', 1);('references', 1);('world health organization', 1);('regional office', 1);('world cancer report cancer research cancer development', 1);('iarc lyon france', 1);('european commission', 1);('european cancer', 1);('information', 1);('online', 1);('available ecisjrceceuropaeu', 1);('accessed', 1);('n howlader', 1);('seer', 1);('statistics review', 1);('laubysecretan', 1);('breastcancer screening viewpoint iarc working', 1);('bakker', 1);('supplemental mri', 1);('dense breast tissue', 1);('england', 1);('medicine', 1);('lauritzen', 1);('protocol breast cancer outcome radiologist workload', 1);('h gail', 1);('projecting', 1);('white females', 1);('j tyrer', 1);('duffy j cuzick', 1);('breast cancer prediction model', 1);('personal risk factors', 1);('stat med', 1);('j n wolfe risk', 1);('breast cancer development', 1);('mammographic parenchymal pattern cancer vol', 1);('boyd', 1);('quantitative', 1);('classification mammographic densities breast cancer risk results', 1);('canadian national breast', 1);('tabr peter', 1);('dean mammographic', 1);('parenchymal patterns risk indicator breast cancer', 1);('jama', 1);('jan', 1);('r r winkel', 1);('stratification women falsepositive test results mammography', 1);('mammographic morphology density case control study cancer', 1);('epidemiol', 1);('external validation', 1);('aidriven', 1);('breast cancer risk prediction model', 1);('diverse cohort women', 1);('iwbi', 1);('qiu', 1);('initial investigation', 1);('new method', 1);('deep learning technology', 1);('imaging', 1);('cad', 1);('kallenberg', 1);('unsupervised', 1);('breast density segmentation mammographic risk', 1);('liu h azizpour', 1);('strand k smith decoupling', 1);('inherent risk', 1);('cancer signs', 1);('miccai', 1);('k dembrower', 1);('comparison', 1);('deep learning risk score', 1);('standard mammographic density score breast cancer risk prediction', 1);('multiinstitutional', 1);('breast cancer risk model journal', 1);('hermann k lampinen', 1);('exploring', 1);('datasets architectures training', 1);('eriksson e', 1);('conant kontos p', 1);('k nishi ding rich hllerer augmentation', 1);('strategies learning noisy labels', 1);('zhang', 1);('generalizing', 1);('medical image segmentation unseen domains', 1);('r volpi h namkoong sener j duchi v murino savarese generalizing', 1);('unseen domains', 1);('adversarial data augmentation', 1);('k roth lucchi nowozin hofmann stabilizing', 1);('training generative adversarial networks regularization', 1);('tortajada', 1);('peripheral area correction digital mammograms', 1);('comput biol med', 1);('k panetta zhou agaian h jia nonlinear', 1);('mammogram enhancement', 1);('ieee transactions information', 1);('biomedicine', 1);('k x zhang ren j sun deep', 1);('residual learning image recognition', 1);('russakovsky', 1);('large scale visual recognition challenge', 1);('int j comput vis', 1);('dec', 1);('p kingma j ba adam', 1);('method stochastic optimization', 1);('iclr', 1);('e r delong delong', 1);('clarkepearson comparing', 1);('characteristic curves nonparametric approach', 1);('biometrics', 1);('x wang huang', 1);('li h dai', 1);('f song', 1);('k chen assessment', 1);('breast cancer risk systematic review metaanalysis trial sequential analysis', 1);('cancer research vol', 1);('mar', 1);('mccarthy', 1);('performance', 1);('breast cancer riskassessment models', 1);('large mammography cohort', 1);('x yang', 1);('prospective', 1);('multifactorial breast cancer risk prediction model', 1);('large prospective cohort study', 1);('j med genet', 1);('sep', 1);